模联立场文件(英文)模联立场文件(英文)
Delegate:Yuqi Zhao Xuezhang Wu
School: Shanxi Experimental Secondary School
Country:Saudi Arabia
Committee: Human Right Council
Topic: Access to pharmaceutical drugs
Since the Penicillin first being used,most of the population had said goodbye...
模联立场文件(英文)
Delegate:Yuqi Zhao Xuezhang Wu
School: Shanxi Experimental Secondary School
Country:Saudi Arabia
Committee: Human Right Council
Topic: Access to pharmaceutical drugs
Since the Penicillin first being used,most of the population had said goodbye to some simple bacterial infections and it had satrted a new century of human history. But now almost two billion people still lack access to essential medicines especilly in Africa and South-East Asia. It means that improving access to existing medicines could save ten million lives each year at least.
Providing some of the poorest can in africa essentital medicines has become one important duty to Saudi Arabia since the first time WHO call on all the developed country to notice the people’s living in Sub-Sahara africa. And the government of
Saudi Arabia is now facing a great challenge, some pharmaceutical companies hold the patent right and the price of some medicines becomes unaffordable and it has become the main limit of the medicines providing. Some countries also hold their position to protect their medical industry and make the price become even higher.
Meanwhile Saudi Arabia itself also faces a serious situation, almost 80% of medicines depend on import. The government spend more than one billion dollar in importing medicines and it also put our government under great pressure. And we are looking forward to find some means to let the price of some essential but expensive medicines down under the acceptable areas.
To improve people’s living all around the world we have to balance two interest. On
one hand we improve our pharmaceutical research standard, on the other hand we have to make sure that all medicines and result we came out really change people’s living situation. We have to protect people’s health first and then the pharmaceutical
companies’ interest. In the other word, we can sacrifice some profit of pharmaceutical companies at the promise of continual development of these companies. And in order to make it work, we suggest the council to come out some effective and strong resolution.
As to the serious situation, we have following solutions:
Reform the list of essential medicines and the rank of each kind of medicines depend on the necessity and the cost. And it will also be consulted by WTO and WIPO.
Shorten the time of patent if this kind of medicines is wildly needed but the company can not offer it enough.
Let each country to pass the law that shorten the time of medical patent and let the
time related to the cost.
Countries which need to import medicines could form a organization and could consult the price so that pharmaceutical companies and factories could get big orders.That could let more medicines into some poor countries in low price.
本文档为【模联立场文件(英文)】，请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑，
图片更改请在作品中右键图片并更换，文字修改请直接点击文字进行修改，也可以新增和删除文档中的内容。
该文档来自用户分享，如有侵权行为请发邮件ishare@vip.sina.com联系网站客服，我们会及时删除。
[版权声明] 本站所有资料为用户分享产生，若发现您的权利被侵害，请联系客服邮件isharekefu@iask.cn，我们尽快处理。
本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权，请谨慎使用。
网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传，仅限个人学习分享使用，禁止用于任何广告和商用目的。
浙公网安备 33021202002483